|
Bone cancer Articles
Bone cancer News : Bone drugs may raise cancer risk Fri, 03 Sep 2010 20:02:17 GMT The family of bone-building drugs that includes Fosamax, Actonel and Boniva can double the risk of developing throat cancer, researchers reported Thursday in the latest development in what has become a confusing discussion. Other studies have reported no increase, but even if the newest finding is correct, the risk is still quite small--about two cases per 1,000 people between age 60 and 79 ...Bone cancer News : Bone drugs may raise risk of throat cancer Thu, 02 Sep 2010 23:01:19 GMT People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests.Bone drug linked to cancer risk Thu, 02 Sep 2010 23:19:16 GMT Long-term use of bone-strengthening drugs may boost the risk of oesophageal cancer, a study suggests.Bone Drugs May Raise Throat Cancer Risk Fri, 03 Sep 2010 01:30:03 GMT Study Finds People Who Take Bone-Strengthening Drugs for Several Years May Have Slightly Higher Risk of Esophageal CancerBone drugs may raise risk of throat cancer Fri, 03 Sep 2010 02:08:48 GMT LONDON (AP) - People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests. The findings are in contrast to another recent study that used the same database of 80,000 patients and concluded that there was no link between the drugs ...Cancer risk 'can be doubled' by taknig drugs to fight bone thinning Fri, 03 Sep 2010 09:42:11 GMT Hundreds of thousands of women taking drugs to combat bone thinning could be doubling their risk of cancer of the oesophagus, warn British researchers.Link between bone drugs and oesophageal cancer Thu, 02 Sep 2010 23:24:18 GMT Long-term use of bone-strengthening drugs - used to treat fractures - may boost the risk of oesophageal cancer, Oxford University research suggests. The study of 3,000 people found taking bisphosphonates for five years upped the risk from one in 1,000 to two in 1,000 for 60 to 79-year-olds.Common bone drugs linked to oesophageal cancer risk Thu, 02 Sep 2010 23:18:54 GMT Source: Reuters * Study is first to find gullet cancer link to long-term use * Bisphosphonates are widely prescribed for bone weakness * Patients should continue on drugs, watch for warning signs By Kate ...Bone drugs may raise cancer risk Fri, 03 Sep 2010 05:16:20 GMT People who take many bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study says.New study links bone drugs to esophageal cancer risk Fri, 03 Sep 2010 02:44:17 GMT People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study ...Bone drugs may double esophageal cancer risk Fri, 03 Sep 2010 16:50:17 GMT People who take a kind of osteoporosis drug named bisphosphonates for more than half a decade may double the risk of getting esophagus cancer, according to Reuters on Friday.Common bone drugs linked to esophageal cancer risk Sat, 04 Sep 2010 04:40:46 GMT LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday.Bone Medicines May Increase Risk of Esophageal Tumors, Researchers Find Thu, 02 Sep 2010 23:29:35 GMT A group of drugs used to prevent bone loss in osteoporosis patients may increase the risk of contracting cancer of the esophagus, a new study found.Bone drugs may raise risk of throat cancer Fri, 03 Sep 2010 12:12:52 GMT In the new study, British researchers looked at nearly 3,000 people with esophageal cancer and matched each one to five similar people who didn't have the disease.Drugs to fight bone thinning double cancer risk Fri, 03 Sep 2010 09:53:42 GMT London, Sep 3 : Hundreds of thousands of women taking drugs to reverse bone thinning could be doubling their oesophagus (gut) cancer risk.Osteoporosis drug linked to cancer Sat, 04 Sep 2010 00:45:56 GMT OXFORD, England, Sept. 3 (UPI) -- Long-term use of oral bisphosphonates -- used to prevent bone loss -- may double the risk of developing esophageal cancer, researchers in Britain say. Osteoporosis - Esophageal cancer - Health - Cancer - EnglandCommon bone drugs linked to oesophageal cancer risk Thu, 02 Sep 2010 23:01:09 GMT * Study is first to find gullet cancer link to long-term useStudy suggest PET/CT scanning may offer effective breast cancer detection Sat, 04 Sep 2010 04:57:34 GMT About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Controversy continues to surround the question of whether CT and bone scans should be standard in evaluating patients for these metastases, or whether integrated PET/CT scanning might be ...Long Term Use Of Oral Bisphosphonates May Double Risk Of Esophageal Cancer Sat, 04 Sep 2010 00:00:14 GMT Research: Oral bisphosphonates and risk of cancer of the esophagus, stomach and colorectum: Case-control analysis within a UK primary care cohortPeople who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published on bmj.com today.Oral bisphosphonates are a type of drug used to ...Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer Thu, 02 Sep 2010 23:08:12 GMT THURSDAY, Sept. 2 (HealthDay News) -- People with osteoporosis who take drugs such as Boniva (ibandronate), Fosamax (alendronate) or Actonel (risedronate) to strengthen their bones may be at an increased risk of esophageal cancer, British researchers report.Afferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain Fri, 03 Sep 2010 12:27:11 GMT Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecules that target P2X3 receptors, announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist significantly prevented and reversed bone cancer pain behavior in comparison to vehicle controls. These data expand on earlier findings and reveal that a ...Bone disease drug 'link' to cancer Thu, 02 Sep 2010 23:11:46 GMT People taking a certain type of drug for osteoporosis could be doubling the risk of developing cancer of the oesophagus research has found.Study Raises New Questions About Bone Drugs, Cancer Risk Fri, 03 Sep 2010 14:51:28 GMT Osteoporosis drugs like Actonel, Boniva, and Fosamax could double the risk of esophageal cancer if they are used over a long period of time, according to the findings from a new study. The research, which was funded by Britainâs Medical Research Council and Cancer Research UK, was published today in the British Medical Journal. Actonel, [...]Cancer inspires her to run - read her story to see how to help Fri, 03 Sep 2010 15:23:17 GMT Dawn Carr has experienced firsthand what cancer can take in the last seven years. Sheâs also learned how the disease can inspire people to give. In 2004, cancer took 7 inches of her colon and 26 lymph nodes. Carr was pregnant at the time, and...Cancer risk seen in drugs to combat brittle bones Fri, 03 Sep 2010 12:26:25 GMT Duelling studies differ over potential links between esophageal cancer and bisphosphonates, widely used after menopause to prevent or treat osteoporosisUsing PET/CT in the Detection of Breast Cancer Metastases Fri, 03 Sep 2010 13:19:25 GMT About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Results from a recent retrospective study conducted by Memorial Sloan-Kettering Cancer Center investigators suggest that PET/CT scanning might offer the most efficient and effective ...Catherine Zeta-Jones Angry About Michael Douglasβ Cancer Ordeal Fri, 03 Sep 2010 10:32:29 GMT Michael Douglas getting cancer came as a nasty surprise for everyone. Most of all to his wife, Catherine Zeta-Jones, who has a bone to pick with his doctors. She revealed, âIt makes me furious they didnât detect it earlier. He sought every option and nothing was found.â Apparently, Douglas had been steadily complaining about pain in his ear and throat. Catherine is incredibly surprised none of ...Dad cycles to make cancer cures easier to survive Sat, 04 Sep 2010 01:11:30 GMT Beating cancer is a tough battle for anyone, but when it's a child it's especially daunting. Bob D'Antoni is a Louisville dad who is training for a second fundraising mission with the Ride to Conquer Cancer. He wants to help fund research to make the battle easier on the body, a fight he knows well after facing it on two difficult fronts.Cancer lad to tackle fund-raising walk Fri, 03 Sep 2010 12:52:41 GMT A FIVE-year-old boy who has battled through 12 months of cancer treatment is preparing to walk 3km in memory of his older cousin, who died from the same disease.Long term use of oral bisphosphonates may double risk of esophageal cancer, study finds Fri, 03 Sep 2010 01:23:25 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing esophageal cancer (cancer of the gullet), according to a new study.Long term use of oral bisphosphonates may double risk of esophageal cancer Thu, 02 Sep 2010 23:31:59 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing esophageal cancer (cancer of the gullet), according to a new study published on bmj.com today.Cancer Survivors' Project Puts Together the Broken Pieces Thu, 02 Sep 2010 04:36:21 GMT Cancer survivors, patients, and those who were left behind have found a new and unique way of coping... and hope it will help others heal, too.Drugs used to treat osteoporosis not linked with higher risk of esophageal cancer Fri, 03 Sep 2010 01:22:55 GMT Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a new study.Long term use of oral bisphosphonates may double risk of esophageal cancer Thu, 02 Sep 2010 23:32:19 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published in the British Medical Journal today.Osteoporosis drug 'doubles cancer risk' Fri, 03 Sep 2010 06:43:56 GMT London, Sep 03 : A new study has shown that people who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet).Common Osteoporosis Drug Linked To Higher Risk Of Oesophageal Cancer Fri, 03 Sep 2010 12:26:31 GMT A new UK study that followed a large number of people found that those who took 10 or more prescriptions for oral bisphosphonates, a group of drugs commonly used to treat the bone disease osteoporosis, were at higher risk of developing oesophageal cancer. You can read about the research behind this finding in a paper published online in the British Medical Journal, BMJ on 2 September...Bradley Brock, Central High School senior, looses battle with cancer Sat, 04 Sep 2010 02:34:21 GMT Bradley Brock â the Sullivan High School senior who inspired his classmates as he battled cancer â wanted to live long enough to see his 18th birthday.Osteoporosis medicines βdo not run cancer risksβ Sat, 04 Sep 2010 01:36:25 GMT THE Irish Medicines Board said it did not consider certain medications for osteoporosis could increase the risk of cancer.Stevensville cancer victim undergoes surgery Thu, 02 Sep 2010 19:12:56 GMT Doctors have been able to save the leg of a 14-year-old Stevensville boy who's battling a rare form of bone cancer.Drugs prescribed for osteoporosis linked to increased risk of cancer Fri, 03 Sep 2010 15:08:45 GMT LONG-TERM use of drugs prescribed for osteoporosis may be doubling the users' risk of developing cancer of the oesophagus, a study warns.Benefit Saturday will help young cancer patient Fri, 03 Sep 2010 16:32:00 GMT When 22-year-old Cordeitra Cooper found out she had breast cancer after undergoing major back surgery, she never cried. âI never saw the diagnosis as a death sentence or a detour in my life,â she said. âIt was more like accepting Godâs plan and being able to use it as a testimonial.âOsteoporosis drugs may raise throat cancer risk Thu, 02 Sep 2010 23:11:51 GMT Researchers say new findings shouldn't affect patients taking bisphosphonates, but said the medicines should be watched closely. Other studies have been divided over whether the risk is real. Cancer - Osteoporosis - Health - Bisphosphonate - Conditions and DiseasesCapsaicin linked to skin cancer Fri, 03 Sep 2010 05:27:12 GMT The September cover story of the nation's leading cancer journal, "Cancer Research," features a new study from The Hormel Institute, University of Minnesota, that links capsaicin, a component of chili peppers, to skin cancer. While the molecular mechanisms of the cancer-promoting effects of capsaicin are not clear and remain controversial, The Hormel Institute has shown a definite connection to ...Life After Cancer, Not A Heavy Burden Fri, 03 Sep 2010 05:13:41 GMT Colorado Springs breast cancer survivor turns Olympic weight lifterHer Make-A-Wish gift lays the groundwork for future Fri, 03 Sep 2010 19:46:02 GMT She survived cancer and was about to get a Make-A-Wish dream, but then she developed a second cancer that kept her out of class her entire junior year at Shepard High School in Palos Heights. But Kahla Harper worked hard with tutors and was able to keep up and graduate with honors. Now Harper, 18, of Calumet Park, finally is getting something really special from the Make-a-Wish Foundation -- not ...Osteoporosis Drugs May Be Linked to Cancer Risk Thu, 02 Sep 2010 23:30:07 GMT The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users remains small, researchers say.Drug 'doubles cancer risk' Fri, 03 Sep 2010 00:17:14 GMT A DRUG taken by thousands of osteoporosis sufferers could double their risk of developing cancer of the gullet.Osteoporosis drug may double risk of oesophageal cancer Fri, 03 Sep 2010 05:13:06 GMT People taking a certain type of drug for osteoporosis could be doubling the risk of developing cancer of the oesophagus.Osteoporosis drug 'doubles cancer risk' Thu, 02 Sep 2010 23:32:01 GMT Drug taken by more than a million people with osteoporosis could increase risk of cancer of the oesophagus, study warns. |
Infectious and parasitic diseases |
|
|
< Home > |
||